Recent studies have detected dysregulated expression of PCAT19 across various human cancer specimens (Xu et al., 2019; Zhang X. et al., 2019; Xie and Hu, 2020; Feng et al., 2023; Acha-Sagredo et al., 2020; Xiao et al., 2022; Tang et al., 2021; Wang B. et al., 2022). The gene discussed is PCAT19; the disease is cancer.